Dow Development Labs LLC

Liquid and semi-solid drug products are our core expertise. Dow Development Laboratories develops, manufactures, and tests topical semi-solid and liquid oral products for clinical use. Products are designed to be disease-compatible, cosmetically elegant & stable, and are filled, packaged & labeled in house and distributed to clinical sites. Our formulation, analytical, production, quality, & clinical labeling teams have decades of experience moving products quickly toward regulatory approval, as does parent company, Symbio, a clinical CRO.